Fundz

Forlong Biotechnology raises approximately 120 million RMB (USD 17.5 million) in Series Pre-B financing, co-led by Fudan Capital, to advance its IL-15 and IL-18 pipeline.

PRIVATEMay 19, 2026

Amount Raised

$17.5 Million

Round Type

Funding Round

Wujiang DistrictBiotechnologyHealth CareTherapeutics

Investors

Changshu Guofa VentureKunsheng Relay FundFudan Capital

Description

Forlong Biotechnology announced the completion of an RMB 120 million (approximately USD 17.5 million) Series Pre-B financing. The round was co-led by an undisclosed fund and Fudan Capital, along with other investors. Proceeds will advance its lead asset, FL115, into pivotal clinical stages. Forlong focuses on developing cytokine therapies for significant unmet medical needs.

Quick answer

Forlong Biotechnology raised $17.5 Million in a Funding Round round, dated May 19, 2026. Investors: Changshu Guofa Venture, Kunsheng Relay Fund and Fudan Capital. Forlong Biotechnology is based in Wujiang District, Jiangsu, China.

How much did Forlong Biotechnology raise?
Forlong Biotechnology raised $17.5 Million in a Funding Round round on May 19, 2026.
Who invested in Forlong Biotechnology?
Changshu Guofa Venture, Kunsheng Relay Fund and Fudan Capital are named as investors in this round.
What does Forlong Biotechnology do?
Forlong Biotechnology is a clinical-stage biotech company focused on developing transformative cytokine therapies for patients with severe unmet needs.
Where is Forlong Biotechnology based and how big is it?
Forlong Biotechnology is based in Wujiang District, Jiangsu, China.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Forlong Biotechnology that raised within 45 days of this round, from Fundz verified event records.

  • ARIBIO raised $28M (Corporate Round) on July 3, 2026.
  • NewcelX raised $2.9M on July 3, 2026.
  • Celea Therapeutics raised $180M (Funding Round) on July 2, 2026.
  • Pictor raised $7.5M (Funding Round) on July 1, 2026.
  • AbSci Corp raised $40M (Funding Round) on July 1, 2026.
  • Amlogenyx raised $10M on July 1, 2026.

Who to call at Forlong Biotechnology, and when

A new round usually means Forlong Biotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Forlong Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Forlong Biotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Forlong Biotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Forlong Biotechnology

Location

Wujiang District, Jiangsu, China

About

Forlong Biotechnology is a clinical-stage biotech company focused on developing transformative cytokine therapies for patients with severe unmet needs. The company has established globally leading technology platforms including Fbody® and Syntokine®, and its lead asset FL115 has shown best-in-class potential inPhase I clinical trials. Forlong aims to advance its pipeline of cytokine therapeutics to address significant medical challenges.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Forlong Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Forlong Biotechnology's next move

See what Strategic adds

Forlong Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.